FDA Inspection 826074 — Michael L. Levin, M.D.

Michael L. Levin, M.D. — FEI 3010043160

The FDA completed an inspection of Michael L. Levin, M.D. on April 3, 2013 in Las Vegas, NV. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 3, 2013
Fiscal Year
2013
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Las Vegas, NV (United States)

Additional Details

Clinical Investigator (CI)